News and Features
Related to Schizophrenia

March 28, 2008 -- New research points to what scientists say are genetic clues to very early signs of schizophrenia in children. Scientists say they've identified a host of genetic mutations that are far more common in people with schizophrenia than in healthy people. While the mutations are rare, t

Nov. 6, 2007 -- The FDA has approved the atypical antipsychotic drug Abilify for the treatment of schizophrenia in teens aged 13-17. Atypical antipsychotic drugs are a newer type of antipsychotic drugs. It's only the second drug specifically approved to treat schizophrenia in teens. Last August, the

Sept. 4, 2007 -- An experimental new drug may prove to be new way to treat schizophrenia, new research shows. A study published in the advance online edition of the journal Nature Medicine highlights the new schizophrenia drug, which doesn't have a catchy name yet. The drug, which is being developed

Aug. 22, 2007 -- The FDA today approved the antipsychotic drug Risperdal to treat schizophrenia in teens and bipolar disorder in some youths. Specifically, Risperdal may be used to treat schizophrenia in adolescents aged 13-17 and for the short-term treatment of manic or mixed episodes of bipolar I

March 21, 2007 -- Scientists say they have discovered a tiny chunk of DNA that may affect schizophrenia risk. The DNA chunk is located near two genes -- the CSF2RA and IL3RA genes -- that haven't been linked to schizophrenia before. The researchers who spotted the DNA chunk included Todd Lencz, PhD,

Dec. 20, 2006 -- The FDA today approved a new antipsychotic drug, called Invega Extended-Release Tablets, to treat schizophrenia. The new drug -- a pill to be taken once a day -- will be available in the U.S. in January. The recommended dose range is 3-12 milligrams daily. Invega is the first new pr

May 31, 2006 – A statistical "signal" links Risperdal and other schizophrenia drugs to pituitary tumors, FDA researchers report. The finding is not proof that these extremely useful drugs cause these benign (noncancerous) tumors. And it does not tell how often patients develop drug-linked pituitary

May 3, 2006 -- A gene called dysbindin-1 (DTNBP1) may be tied to intelligence, scientists report in Human Molecular Genetics. The scientists studied a region of a particular chromosome. That chromosome region is where the DTNBP1 gene is located. The DTNBP1 gene has previously been associated with sc

Sept. 19, 2005 -- Mental health experts say it wasn't a horse race. That explains why there's no clear winner from a major government study pitting a new generation of schizophrenia drugs against one another. Zyprexa was the most effective of the drugs. But its greater number of side effects dims it

May 31, 2005 -- Schizophrenia Schizophrenia may be less common than experts previously thought. Until now, the often-quoted statistic was that schizophrenia strikes about one in 100 people, say Australian researchers. That's an overestimate, they write in the Public Library of Science Medicine's May